45 results on '"Gunapala R"'
Search Results
2. OC-0106 Late Toxicity and Efficacy of Hypofractionated Prostate RT with Focal Boost in the DELINEATE trial
3. Fractionated Stereotactic Conformal Radiotherapy for Optic Nerve Sheath Meningiomas
4. A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12 weeks
5. Practice of routine oral zinc supplementation during diarrheal illnesses in children
6. Patient factors, health care factors and survival from lung cancer according to ethnic group in the south of London, UK
7. P1.01-79 G8 Screening Scores in Elderly Advanced Lung Cancer Patients: A Prospective Single Institution Study
8. Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls
9. Bacterial pathogens causing urinary tract infections in children and their antimicrobial susceptibility patterns in a tertiary care hospital in Sri Lanka
10. Phase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC
11. The impact of the UK Government ‘two week rule’ (TWR) on lung cancer stage and 5-year survival – a decade of experience from the Royal Marsden Hospital (RMH)
12. Less frequent monitoring of response in patients with advanced thoracic malignancies receiving palliative chemotherapy, does not adversely impact patient care
13. P3.12-003 Optimized Inhaler Therapy Is Superior to Supportive Care Alone for Dyspnea in Patients with Coexisting COPD and Lung Cancer
14. P1.03-029 Study of Plasma Homocysteine as a Marker of Toxicity and Depression in Patients Treated with Pemetrexed-Based Chemotherapy
15. 69: Outcomes with nintedanib and docetaxel in patients with relapsed NSCLC adenocarcinoma treated within the UK Nintedanib Individual Patient Supply programme
16. A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma
17. A case of Long QT syndrome
18. 163 A randomised study comparing the effectiveness of acupuncture (A) or morphine (M) versus the combination (AM) for the relief of dyspnoea in patients with advanced non small cell lung cancer and mesothelioma
19. A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic
20. 1465P - Phase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC
21. Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres
22. Thrips on Rice-Sri Lanka
23. An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
24. A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic.
25. Brown Plant Hopper (BPH) on Rice-Sri Lanka
26. 38 Patterns of relapse and detection method in patients with resected non-small cell lung cancer (NSCLC) – a single institution experience
27. Leaf folder on rice-Sri Lanka
28. 33 Outcomes of patients undergoing adjuvant platinum–vinorelbine chemotherapy for resected non-small cell lung cancer (NSCLC)
29. Patient factors, health care factors and survival from lung cancer according to ethnic group in the south of London, UK
30. 76 The UK ‘two week rule’ for lung cancer – 5-year survival update
31. A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks.
32. Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
33. Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI.
34. A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancer.
35. Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial.
36. A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.
37. Spect perfusion imaging versus CT for predicting radiation injury to normal lung in lung cancer patients.
38. Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.
39. A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
40. Resolution of severe hyponatraemia is associated with improved survival in patients with cancer.
41. An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity.
42. A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice.
43. A pilot study of a novel home telemonitoring system for oncology patients receiving chemotherapy.
44. Diethylstilbestrol in castration-resistant prostate cancer.
45. A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeks.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.